DRAVP ID  DRAVPa2465

Peptide Name   Sequence 1 from Patent CN117843735A

Sequence  PAYTNSFTRGVYYPD

Sequence Length  15

Source  Synthetic construct

Target Organism  SARS-CoV-2

Patent Type  Patent Application

Publication Date  2024-04-09

Patent No  CN117843735A

Family Info  CN 117843735 A

Patent Title  Novel specific CD4T cell epitope peptide for screening coronavirus S1 holoproteome and application of specific CD4T cell epitope peptide

Comment 

Abstract  The invention discloses a specific CD4T cell epitope peptide for screening a novel coronavirus S1 holoproteome and application of the specific CD4T cell epitope peptide, relates to the technical field of biological medicines, and is technically characterized in that the scheme of the invention provides a novel coronavirus CD4T cell epitope peptide. The invention also relates to a gene for coding the epitope polypeptide, a recombinant protein or a compound containing the epitope polypeptide, a sensitization antigen presenting cell and a specific immune effector cell aiming at the epitope polypeptide in research and development of novel coronavirus vaccines and disease treatment. The specific CD4T cell epitope peptide screened by the novel coronavirus S1 holoproteome can safely and effectively induce CD4T cell immune response aiming at novel coronavirus protein, and has important significance on research and development of novel vaccines of novel coronavirus.